The new units will be integrated to a new structure adjacent to the Maisonneuve-Rosemont Hospital
Quebec-based Mecart has started shipping modular isolation rooms for COVID-19 patients to a major Montreal hospital.
Fully assembled at the Mecart plant, the units will be integrated to a new structure adjacent to the Maisonneuve-Rosemont Hospital, built by well-known general contractor Pomerleau.
Mecart President Benoît Poupart and VP and general manager, Patrice Genois, said they were "proud that, with its expertise and capabilities, Mecart was in a position to contribute in a significant way to the fight against COVID-19". The isolation chambers provided by Mecart will be used for COVID-19 patients and subsequently for immunosuppressed patients in oncology, allowing long-term use of the investment after the pandemic.
Founded in 1974 and under the current ownership since 2012, Mecart specialises in controlled environments, such as cleanrooms and laboratories which it engineers, manufactures and installs globally.
Mecart custom modular cleanrooms can be found in many fields, from health-related applications such as pharmaceuticals, hazardous pharmacy compounding, research and clinical trials to industrial sectors such as electronics, aerospace and nanofabrication. This same technology and expertise allow the company to supply much-needed medical isolation rooms to hospitals and healthcare facilities with short lead-times.